366 related articles for article (PubMed ID: 12534505)
1. Comparison of botulinum toxin types A and B: a bilateral and double-blind randomized evaluation in the treatment of canthal rhytides.
Matarasso SL
Dermatol Surg; 2003 Jan; 29(1):7-13; discussion 13. PubMed ID: 12534505
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type B for dynamic glabellar rhytides refractory to botulinum toxin type A.
Alster TS; Lupton JR
Dermatol Surg; 2003 May; 29(5):516-8. PubMed ID: 12752520
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of incobotulinum toxin A in periocular rhytides and masseteric hypertrophy: side-by-side comparison with onabotulinum toxin A.
Lee JH; Park JH; Lee SK; Han KH; Kim SD; Yoon CS; Park JY; Lee JH; Yang JM; Lee JH
J Dermatolog Treat; 2014 Aug; 25(4):326-30. PubMed ID: 23356833
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin types A and B: comparison of efficacy, duration, and dose-ranging studies for the treatment of facial rhytides and hyperhidrosis.
Yamauchi PS; Lowe NJ
Clin Dermatol; 2004; 22(1):34-9. PubMed ID: 15158543
[TBL] [Abstract][Full Text] [Related]
5. Effect of botulinum toxin type A on movement-associated rhytides following CO2 laser resurfacing.
West TB; Alster TS
Dermatol Surg; 1999 Apr; 25(4):259-61. PubMed ID: 10417577
[TBL] [Abstract][Full Text] [Related]
6. A two-center, open-label, randomized, split-face study to assess the efficacy and safety of one versus three intradermal injection sites of abobotulinumtoxinA in the treatment of lateral periocular rhytides.
Fabi SG; Sundaram H; Guiha I; Goldman MP
J Drugs Dermatol; 2013 Aug; 12(8):932-7. PubMed ID: 23986168
[TBL] [Abstract][Full Text] [Related]
7. A prospective, double-blind, randomized, parallel- group, dose-ranging study of botulinum toxin type a in female subjects with horizontal forehead rhytides.
Carruthers A; Carruthers J; Cohen J
Dermatol Surg; 2003 May; 29(5):461-7. PubMed ID: 12752512
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type a injection for lateral canthal rhytids : effect on tear film stability and tear production.
Ho MC; Hsu WC; Hsieh YT
JAMA Ophthalmol; 2014 Mar; 132(3):332-7. PubMed ID: 24385079
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type B (MYOBLOC) versus botulinum toxin type A (BOTOX) frontalis study: rate of onset and radius of diffusion.
Flynn TC; Clark RE
Dermatol Surg; 2003 May; 29(5):519-22; discussion 522. PubMed ID: 12752521
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.
Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Moore D
J Cosmet Laser Ther; 2002 Mar; 4(1):15-8. PubMed ID: 12079632
[TBL] [Abstract][Full Text] [Related]
11. Decreased tear expression with an abnormal Schirmer's test following botulinum toxin type A for the treatment of lateral canthal rhytides.
Matarasso SL
Dermatol Surg; 2002 Feb; 28(2):149-52. PubMed ID: 11860426
[TBL] [Abstract][Full Text] [Related]
12. Correlation of botulinum toxin dose with neurophysiological parameters of efficacy and safety in the glabellar muscles: a double-blind, placebo-controlled, randomized study.
Alimohammadi M; Andersson M; Punga AR
Acta Derm Venereol; 2014 Jan; 94(1):32-7. PubMed ID: 23975053
[TBL] [Abstract][Full Text] [Related]
13. Alteration of Skin Mechanical Properties in Patients Undergoing Botulinum Toxin Type A Injections of Forehead Rhytides.
Min P; Zhang Z; Grassetti L; Perdanasari AT; Torresetti M; Pu Z; Zhang Y; Han S; Marsili R; Zhang YX; di Benedetto G; Lazzeri D
Aesthetic Plast Surg; 2016 Jun; 40(3):410-20. PubMed ID: 26944891
[TBL] [Abstract][Full Text] [Related]
14. Addition of an anesthetic agent to enhance the predictability of the effects of botulinum toxin type A injections: a randomized controlled study.
Gassner HG; Sherris DA
Mayo Clin Proc; 2000 Jul; 75(7):701-4. PubMed ID: 10907385
[TBL] [Abstract][Full Text] [Related]
15. Oculoplastic experience with the cosmetic use of botulinum A exotoxin.
Edelstein C; Shorr N; Jacobs J; Balch K; Goldberg R
Dermatol Surg; 1998 Nov; 24(11):1208-12. PubMed ID: 9834740
[TBL] [Abstract][Full Text] [Related]
16. Effect of botulinum toxin pretreatment on laser resurfacing results: a prospective, randomized, blinded trial.
Zimbler MS; Holds JB; Kokoska MS; Glaser DA; Prendiville S; Hollenbeak CS; Thomas JR
Arch Facial Plast Surg; 2001; 3(3):165-9. PubMed ID: 11497500
[TBL] [Abstract][Full Text] [Related]
17. Comparison of botulinum toxins A and B in the aesthetic treatment of facial rhytides.
Sadick NS; Herman AR
Dermatol Surg; 2003 Apr; 29(4):340-7. PubMed ID: 12656810
[TBL] [Abstract][Full Text] [Related]
18. Sebum Production Alteration after Botulinum Toxin Type A Injections for the Treatment of Forehead Rhytides: A Prospective Randomized Double-Blind Dose-Comparative Clinical Investigation.
Min P; Xi W; Grassetti L; Trisliana Perdanasari A; Torresetti M; Feng S; Su W; Pu Z; Zhang Y; Han S; Zhang YX; Di Benedetto G; Lazzeri D
Aesthet Surg J; 2015 Jul; 35(5):600-10. PubMed ID: 25825422
[TBL] [Abstract][Full Text] [Related]
19. The use of botulinum toxin type A in cosmetic facial procedures.
Jaspers GW; Pijpe J; Jansma J
Int J Oral Maxillofac Surg; 2011 Feb; 40(2):127-33. PubMed ID: 20965695
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin type B for glabellar wrinkles: a prospective open-label response study.
Sadick NS; Faacs
Dermatol Surg; 2002 Sep; 28(9):817-21. PubMed ID: 12269875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
